FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035834282> ?p ?o ?g. }

• W2035834282 endingPage "444" @default.
• W2035834282 startingPage "435" @default.
• W2035834282 abstract "A novel karenitecin, BNP1350, is a topoisomerase I-targeting anticancer agent with significant antitumor activity in vitro and in vivo. A BNP1350-resistant human head and neck carcinoma A253 cell line, denoted A253/BNPR, was developed. The A253/BNPR cell line was approximately 9-fold resistant to BNP1350 and 4-fold cross-resistant to another topoisomerase I inhibitor SN-38, the active metabolite of irinotecan. After drug treatment with equimolar concentrations of BNP1350 (0.7 microM) for 2h, activation of the DNA double-strand break repair protein complexes was similar in the two cell lines, suggesting that DNA dsb repair is not attributable to resistance to BNP1350 in the A253/BNPR cells. Cell cycle analysis indicates that the A253 cell line accumulated primarily in S phase, but G(2) phase accumulation was observed in the A253/BNPR cell line at 48 h after drug removal. Elevated chk1 phosphorylation at Ser(345) following DNA damage induced by BNP1350 was accompanied by G(2) accumulation in the A253/BNPR cell line, while exposure to equimolar concentrations of BNP1350 (0.7 microM) induced S-phase arrest and no increased phosphorylation of chk1 at Ser(345) in the A253 cell line. Under the same conditions, increased chk1 activity was observed in the A253/BNPR cell line, but not in the A253 cell line. Moreover, stimulated binding of 14-3-3 proteins to chk1 was observed in BNP1350-treated A253/BNPR cells. To confirm relationship between chk1 expression/phosphorylation and drug resistance to topo I poisons, we examined the effects of chk1 or chk2 antisense oligonucleotides on the cellular growth inhibition. Chk1 antisense oligonucleotide can sensitize the A253/BNPR cells to killing by topo I inhibitor BNP1350, but no significant sensitization of BNP1350-induced growth inhibition was observed in the drug-sensitive cell line. Chk2 antisense oligonucleotide has only a small sensitization effect on BNP1350-induced growth inhibition in both cell lines. The data indicate that the chk1 signaling pathways that mediate cell cycle checkpoint are associated with cellular resistance to BNP1350 in the A253/BNPR cell line." @default.
• W2035834282 created "2016-06-24" @default.
• W2035834282 creator A5027809681 @default.
• W2035834282 creator A5035116940 @default.
• W2035834282 creator A5040240016 @default.
• W2035834282 creator A5045095134 @default.
• W2035834282 creator A5049919100 @default.
• W2035834282 creator A5059830806 @default.
• W2035834282 creator A5076225093 @default.
• W2035834282 date "2002-07-01" @default.
• W2035834282 modified "2023-10-17" @default.
• W2035834282 title "Chk1 signaling pathways that mediated G2M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350" @default.
• W2035834282 cites W1515564094 @default.
• W2035834282 cites W1520947267 @default.
• W2035834282 cites W1587797958 @default.
• W2035834282 cites W1595184397 @default.
• W2035834282 cites W161377905 @default.
• W2035834282 cites W1618806168 @default.
• W2035834282 cites W163117315 @default.
• W2035834282 cites W1633875338 @default.
• W2035834282 cites W1826133209 @default.
• W2035834282 cites W1905265488 @default.
• W2035834282 cites W192877506 @default.
• W2035834282 cites W1967555518 @default.
• W2035834282 cites W1979035617 @default.
• W2035834282 cites W1986010069 @default.
• W2035834282 cites W1993638752 @default.
• W2035834282 cites W1994909028 @default.
• W2035834282 cites W2013404388 @default.
• W2035834282 cites W2013553237 @default.
• W2035834282 cites W2016501792 @default.
• W2035834282 cites W2024604197 @default.
• W2035834282 cites W2027333133 @default.
• W2035834282 cites W2033950216 @default.
• W2035834282 cites W2034317592 @default.
• W2035834282 cites W2037894077 @default.
• W2035834282 cites W2043548659 @default.
• W2035834282 cites W2043703023 @default.
• W2035834282 cites W2044697175 @default.
• W2035834282 cites W2044868120 @default.
• W2035834282 cites W2048651402 @default.
• W2035834282 cites W2057949133 @default.
• W2035834282 cites W2065022250 @default.
• W2035834282 cites W2076314401 @default.
• W2035834282 cites W2081995373 @default.
• W2035834282 cites W2087310583 @default.
• W2035834282 cites W2091782725 @default.
• W2035834282 cites W2105592350 @default.
• W2035834282 cites W2105768236 @default.
• W2035834282 cites W2109689528 @default.
• W2035834282 cites W2110235974 @default.
• W2035834282 cites W2123273708 @default.
• W2035834282 cites W2134547388 @default.
• W2035834282 cites W2135799569 @default.
• W2035834282 cites W2138414621 @default.
• W2035834282 cites W2144194333 @default.
• W2035834282 cites W2150149139 @default.
• W2035834282 cites W2328369261 @default.
• W2035834282 cites W2329294870 @default.
• W2035834282 cites W4255907357 @default.
• W2035834282 doi "https://doi.org/10.1016/s0006-291x(02)00683-6" @default.
• W2035834282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12150968" @default.
• W2035834282 hasPublicationYear "2002" @default.
• W2035834282 type Work @default.
• W2035834282 sameAs 2035834282 @default.
• W2035834282 citedByCount "22" @default.
• W2035834282 countsByYear W20358342822013 @default.
• W2035834282 countsByYear W20358342822014 @default.
• W2035834282 countsByYear W20358342822017 @default.
• W2035834282 countsByYear W20358342822021 @default.
• W2035834282 crossrefType "journal-article" @default.
• W2035834282 hasAuthorship W2035834282A5027809681 @default.
• W2035834282 hasAuthorship W2035834282A5035116940 @default.
• W2035834282 hasAuthorship W2035834282A5040240016 @default.
• W2035834282 hasAuthorship W2035834282A5045095134 @default.
• W2035834282 hasAuthorship W2035834282A5049919100 @default.
• W2035834282 hasAuthorship W2035834282A5059830806 @default.
• W2035834282 hasAuthorship W2035834282A5076225093 @default.
• W2035834282 hasConcept C143425029 @default.
• W2035834282 hasConcept C147897179 @default.
• W2035834282 hasConcept C1491633281 @default.
• W2035834282 hasConcept C29537977 @default.
• W2035834282 hasConcept C54355233 @default.
• W2035834282 hasConcept C552990157 @default.
• W2035834282 hasConcept C55493867 @default.
• W2035834282 hasConcept C81885089 @default.
• W2035834282 hasConcept C86803240 @default.
• W2035834282 hasConceptScore W2035834282C143425029 @default.
• W2035834282 hasConceptScore W2035834282C147897179 @default.
• W2035834282 hasConceptScore W2035834282C1491633281 @default.
• W2035834282 hasConceptScore W2035834282C29537977 @default.
• W2035834282 hasConceptScore W2035834282C54355233 @default.
• W2035834282 hasConceptScore W2035834282C552990157 @default.
• W2035834282 hasConceptScore W2035834282C55493867 @default.
• W2035834282 hasConceptScore W2035834282C81885089 @default.
• W2035834282 hasConceptScore W2035834282C86803240 @default.
• W2035834282 hasIssue "2" @default.
• W2035834282 hasLocation W20358342821 @default.

• next